Jill Corre (J Corre)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 51

Top Venues

Blood

Blood cancer journal

Nature medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Marie-Lorraine Chretien, Kamel Laribi, Claire Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frederique Orsini-Piocelle, Julie Gay, Benoit Bareau, Noemie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier-Rascalou, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Thorsten Braun, Florence Lachenal, Selim Corm, Celine Kennel, Rakiba Belkhir, Jean-Sebastien Bladé, Bertrand Joly, Valentine Richez-Olivier, Helene Gardeney, Helene Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet-Loiseau, Jill Corre, Thierry Facon
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature medicine 30 (8) (2024)
Jill Corre
Blood, the hidden side of myeloma? Blood 143 (23) (2024)
Anaïs Schavgoulidze, Jill Corre, Mehmet K Samur, Celine Mazzotti, Luka Pavageau, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Margaret Macro, Karim Belhadj, Murielle Roussel, Sabine Brechignac, Lydia Montes, Denis Caillot, Laurent Frenzel, Philippe Rey, Jean Marc Schiano De Colella, Thomas Chalopin, Caroline Jacquet, Valentine Richez, Frederique Orsini Piocelle, Jean Fontan, Salomon Manier, Ludovic Martinet, Adam Sciambi, Mohamad Mohty, Hervé Avet-Loiseau
RAS/RAFlandscape in monoclonal plasma cell conditions. Blood (2024)
Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Marie-Lorraine Chretien, Kamel Laribi, Claire Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frederique Orsini-Piocelle, Julie Gay, Benoit Bareau, Noemie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier-Rascalou, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Thorsten Braun, Florence Lachenal, Selim Corm, Celine Kennel, Rakiba Belkhir, Jean-Sebastien Bladé, Bertrand Joly, Valentine Richez-Olivier, Helene Gardeney, Helene Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet-Loiseau, Jill Corre, Thierry Facon
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature medicine 30 (8) (2024)
Anais Schavgoulidze, Jill Corre, Mehmet Kemal Samur, Celine Mazzotti, Luka Pavageau, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Margaret Macro, Karim Belhadj, Murielle Roussel, Sabine Brechignac, Lydia Montes, Denis Caillot, Laurent Frenzel, Philippe Rey, Jean Marc Schiano De Colella, Thomas Chalopin, Caroline Jacquet, Valentine Richez, Frederique Orsini-Piocelle, Jean Fontan, Salomon Manier, Ludovic Martinet, Adam Sciambi, Mohamad Mohty, Herve Avet-Loiseau
RAS/RAF landscape in monoclonal plasma cell conditions. Blood 144 (2) (2024)
B Ferment, J Lambert, D Caillot, I Lafon, L Karlin, A Lazareth, Cyrille Touzeau, Xavier Leleu, N Moya, S Harel, Aurore Perrot, Pierre Bories, L Vincent, S Lamure, Mohamad Mohty, F Malard, S Manier, I Yakoub-Agha, J-M Schiano De Colella, G Brisou, A Talbot, O Decaux, R Houot, S Le Gouill, N Bigot, T Facon, Jill Corre, Phillipe Moreau, Bertrand Arnulf, null null
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry. British journal of haematology (2024)
Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Marie-Lorraine Chretien, Kamel Laribi, Claire Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frederique Orsini-Piocelle, Julie Gay, Benoit Bareau, Noemie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier-Rascalou, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Thorsten Braun, Florence Lachenal, Selim Corm, Celine Kennel, Rakiba Belkhir, Jean-Sebastien Bladé, Bertrand Joly, Valentine Richez-Olivier, Helene Gardeney, Helene Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet-Loiseau, Jill Corre, Thierry Facon
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature medicine (2024)
Cyrille Touzeau, Aurore Perrot, Cyrille Hulin, Salomon Manier, Margaret Macro, Marie-Lorraine Chretien, Lionel Karlin, Martine Escoffre, Caroline Jacquet, Mourad Tiab, Xavier Leleu, Hervé Avet-Loiseau, Alexandra Jobert, Lucie Planche, Jill Corre, Philippe Moreau
Daratumumab Carfilzomib Lenalidomide and Dexamethasone with tandem transplant in high-risk newly diagnosed myeloma. Blood (2024)
Cyrille Touzeau, Aurore Perrot, Cyrille Hulin, Salomon Manier, Margaret Macro, Marie-Lorraine Chretien, Lionel Karlin, Martine Escoffre, Caroline Jacquet, Mourad Tiab, Xavier Leleu, Hervé Avet-Loiseau, Alexandra Jobert, Lucie Planche, Jill Corre, Philippe Moreau
Daratumumab Carfilzomib Lenalidomide and Dexamethasone with tandem transplant in high-risk newly diagnosed myeloma. Blood (2024)
Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Marie-Lorraine Chretien, Kamel Laribi, Claire Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frederique Orsini-Piocelle, Julie Gay, Benoit Bareau, Noemie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier-Rascalou, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Thorsten Braun, Florence Lachenal, Selim Corm, Celine Kennel, Rakiba Belkhir, Jean-Sebastien Bladé, Bertrand Joly, Valentine Richez-Olivier, Helene Gardeney, Helene Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet-Loiseau, Jill Corre, Thierry Facon
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature medicine (2024)
Anaïs Schavgoulidze, Jill Corre, Mehmet K Samur, Celine Mazzotti, Luka Pavageau, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Margaret Macro, Karim Belhadj, Murielle Roussel, Sabine Brechignac, Lydia Montes, Denis Caillot, Laurent Frenzel, Philippe Rey, Jean Marc Schiano De Colella, Thomas Chalopin, Caroline Jacquet, Valentine Richez, Frederique Orsini Piocelle, Jean Fontan, Salomon Manier, Ludovic Martinet, Adam Sciambi, Mohamad Mohty, Hervé Avet-Loiseau
RAS/RAFlandscape in monoclonal plasma cell conditions. Blood (2024)
Aurore Perrot, Murielle Roussel, Valerie Lauwers-Cances, Cyrille Hulin, Xavier Leleu, Cyrille Touzeau, Thierry Facon, Clara Mariette, Jean-Marc Schiano, Julie Gay, Lydiane Mordier, Dana Ranta, Amandine Huguet, Soraya Wuillème, Thomas Dejoie, Laure Devlamynck, Jill Corre, Hervé Avet-Loiseau, Phillipe Moreau, Michel Attal
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03. British journal of haematology (2024)
Anais Schavgoulidze, Jill Corre, Mehmet Kemal Samur, Celine Mazzotti, Luka Pavageau, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Margaret Macro, Karim Belhadj, Murielle Roussel, Sabine Brechignac, Lydia Montes, Denis Caillot, Laurent Frenzel, Philippe Rey, Jean Marc Schiano De Colella, Thomas Chalopin, Caroline Jacquet, Valentine Richez, Frederique Orsini-Piocelle, Jean Fontan, Salomon Manier, Ludovic Martinet, Adam Sciambi, Mohamad Mohty, Herve Avet-Loiseau
RAS/RAF landscape in monoclonal plasma cell conditions. Blood 144 (2) (2024)
Cyrille Touzeau, Aurore Perrot, Cyrille Hulin, Salomon Manier, Margaret Macro, Marie-Lorraine Chretien, Lionel Karlin, Martine Escoffre, Caroline Jacquet, Mourad Tiab, Xavier Leleu, Herve Avet-Loiseau, Alexandra Jobert, Lucie Planche, Jill Corre, Philippe Moreau
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma. Blood 143 (20) (2024)
Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Marie-Lorraine Chretien, Kamel Laribi, Claire Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frederique Orsini-Piocelle, Julie Gay, Benoit Bareau, Noemie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier-Rascalou, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Thorsten Braun, Florence Lachenal, Selim Corm, Celine Kennel, Rakiba Belkhir, Jean-Sebastien Bladé, Bertrand Joly, Valentine Richez-Olivier, Helene Gardeney, Helene Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet-Loiseau, Jill Corre, Thierry Facon
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. Nature medicine 30 (8) (2024)
Jill Corre
Blood, the hidden side of myeloma? Blood 143 (23) (2024)
Cyrille Touzeau, Aurore Perrot, Cyrille Hulin, Salomon Manier, Margaret Macro, Marie-Lorraine Chretien, Lionel Karlin, Martine Escoffre, Caroline Jacquet, Mourad Tiab, Xavier Leleu, Herve Avet-Loiseau, Alexandra Jobert, Lucie Planche, Jill Corre, Philippe Moreau
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma. Blood 143 (20) (2024)
Eve Blanquart, Rüçhan Ekren, Bineta Rigaud, Marie Veronique Joubert, Virginie Baylot, Hélène Daunes, Marine Cuisinier, Marine Villard, Nadège Carrié, Celine Mazzotti, Liliana E Lucca, Aurore Perrot, Jill Corre, Thierry Walzer, Herve Avet-Loiseau, Pierre-Paul Axisa, Ludovic Martinet
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in Multiple Myeloma. Blood (2024)
Mehmet K Samur, Anil Aktas Samur, Jill Corre, Romain Lannes, Parth Shah, Kenneth C Anderson, Herve Avet-Loiseau, Nikhil C Munshi
Monoallelic Deletion of BCMA is a frequent feature in multiple myeloma. Blood advances (2023)
Somayya Noori, Charissa Wijnands, Pieter Langerhorst, Vincent Bonifay, Christoph Stingl, Cyrille Touzeau, Jill Corre, Aurore Perrot, Philippe Moreau, Hélène Caillon, Theo M Luider, Thomas Dejoie, Joannes F M Jacobs, Martijn M vanDuijn
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry. Blood cancer journal 13 (1) (2023)
Somayya Noori, Charissa Wijnands, Pieter Langerhorst, Vincent Bonifay, Christoph Stingl, Cyrille Touzeau, Jill Corre, Aurore Perrot, Philippe Moreau, Hélène Caillon, Theo M Luider, Thomas Dejoie, Joannes F M Jacobs, Martijn M vanDuijn
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry. Blood cancer journal 13 (1) (2023)
Mehmet K Samur, Marco Roncador, Anil Aktas Samur, Mariateresa Fulciniti, Abdul-Hamid Bazarbachi, Raphael E Szalat, Masood A Shammas, Adam S Sperling, Paul G Richardson, Florence Magrangeas, Stephane Minvielle, Aurore Perrot, Jill Corre, Philippe Moreau, Anjan Thakurta, Giovanni Parmigiani, Kenneth C Anderson, Herve Avet-Loiseau, Nikhil C Munshi
High-Dose Melphalan Treatment Significantly Increases Mutational Burden at Relapse in Multiple Myeloma. Blood (2023)
Mehmet K Samur, Marco Roncador, Anil Aktas Samur, Mariateresa Fulciniti, Abdul-Hamid Bazarbachi, Raphael E Szalat, Masood A Shammas, Adam S Sperling, Paul G Richardson, Florence Magrangeas, Stephane Minvielle, Aurore Perrot, Jill Corre, Philippe Moreau, Anjan Thakurta, Giovanni Parmigiani, Kenneth C Anderson, Herve Avet-Loiseau, Nikhil C Munshi
High-Dose Melphalan Treatment Significantly Increases Mutational Burden at Relapse in Multiple Myeloma. Blood (2023)
Somayya Noori, Charissa Wijnands, Pieter Langerhorst, Vincent Bonifay, Christoph Stingl, Cyrille Touzeau, Jill Corre, Aurore Perrot, Philippe Moreau, Hélène Caillon, Theo M Luider, Thomas Dejoie, Joannes F M Jacobs, Martijn M vanDuijn
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry. Blood cancer journal 13 (1) (2023)
Anaïs Schavgoulidze, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Lydia Montes, Caroline Jacquet, Karim Belhadj, Sabine Brechignac, Laurent Frenzel, Thomas Chalopin, Philippe Rey, Jean-Marc Schiano de Collela, Mamoun Dib, Denis Caillot, Margaret Macro, Jean Fontan, Laure Buisson, Luka Pavageau, Murielle Roussel, Salomon Manier, Florent Malard, Ludovic Martinet, Hervé Avet-Loiseau, Jill Corre
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions. Blood cancer journal 13 (1) (2023)
Eileen Mary Boyle, Patrick Blaney, James H Stoeckle, Yubao Wang, Hussein Ghamlouch, Dylan Gagler, Marc J Braunstein, Louis Williams, Avital Tenenbaum, Ariel M Siegel, Xiaoyi Chen, Gaurav Varma, Jason Avigan, Alexander Li, Monica Jinsi, David Kaminetzky, Arnaldo Arbini, Lydiane Mordier, Jill Corre, Even Holth Rustad, Carl Ola Landgren, Francesco Maura, Brian A Walker, Michael A Bauer, Benedetto Bruno, Aristotelis Tsirigos, Faith E Davies, Gareth J Morgan
Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Titouan Cazaubiel, Xavier Leleu, Aurore Perrot, Salomon Manier, Laure Buisson, Sabrina Maheo, Laura Do Souto Ferreira, Romain Lannes, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Brechignac, Margaret Macro, Anne-Marie Stoppa, Laurence Sanhes, Frédérique Orsini-Piocelle, Jean Fontan, Marie-Lorraine Chretien, Hélène Demarquette, Mohamad Mohty, Anaïs Schavgoulidze, Herve Avet-Loiseau, Jill Corre
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features. Blood 139 (17) (2022)
Alban Canali, Jill Corre, Brigitte Riviere, Pauline Condom, Jean Baptiste Rieu
Monoclonal plasma cells with normal phenotype can lead to diagnosis of small B-cell lymphoma. EJHaem 3 (4) (2022)
Romain Lannes, Mehmet Kemal Samur, Aurore Perrot, Celine Mazzotti, Marion Divoux, Titouan Cazaubiel, Xavier Leleu, Anaïs Schavgoulidze, Marie-Lorraine Chretien, Salomon Manier, Didier Adiko, Frederique Orsini-Piocelle, François Lifermann, Sabine Brechignac, Lauris Gastaud, Didier Bouscary, Margaret Macro, Alice Cleynen, Florent Malard, Nikhil C Munshi, Jill Corre, Herve Avet-Loiseau
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Anaïs Schavgoulidze, Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Salomon Manier, Laure Buisson, Sabrina Mahéo, Laura Do Souto Ferreira, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Brechignac, Margaret Macro, Anne Marie Stoppa, Laurence Sanhes, Frederique Orsini Piocelle, Jean Fontan, Marie-Lorraine Chretien, Hélène Demarquette, Mohamad Mohty, Herve Avet-Loiseau, Jill Corre
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor. Blood (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Sahar Kassem, Béré K Diallo, Nizar El-Murr, Nadège Carrié, Alexandre Tang, Alain Fournier, Hélène Bonnevaux, Céline Nicolazzi, Marine Cuisinier, Isabelle Arnould, Sukhvinder S Sidhu, Jill Corre, Herve Avet-Loiseau, Jean-Luc Teillaud, Helgi van de Velde, Dmitri Wiederschain, Marielle Chiron, Ludovic Martinet, Angela Virone-Oddos
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. Blood 139 (8) (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Nicholas Stong, Maria Ortiz Estevez, Fadi Towfic, Mehmet K Samur, Amit Agarwal, Jill Corre, Erin Flynt, Nikhil C Munshi, Herve Avet-Loiseau, Anjan Thakurta
Location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of high-risk NDMM patients. Blood (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Herve Avet-Loiseau, Jill Corre, Michel Attal
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study. Blood 139 (18) (2022)
Jill Corre
Why is amyloidosis not multiple myeloma? Blood 138 (17) (2021)
Abdul-Hamid Bazarbachi, Hervé Avet-Loiseau, Raphael Szalat, Anil Aktas Samur, Zachary R Hunter, Masood A Shammas, Jill Corre, Mariateresa Fulciniti, Kenneth C Anderson, Giovanni Parmigiani, Steven P Treon, Mohamad Mohty, Nikhil C Munshi, Mehmet Kemal Samur
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM. Blood 138 (20) (2021)
Jill Corre, Aurore Perrot, Cyrille Hulin, Denis Caillot, Anne-Marie Stoppa, Thierry Facon, Xavier Leleu, Mamoun Dib, Lionel Karlin, Philippe Moreau, Mohamad Mohty, Clara Mariette, Jean Fontan, Jean-Pierre Marolleau, Hélène Demarquette, Borane Slama, Laurent Voillat, Margaret Macro, Frédérique Orsini-Piocelle, Sabine Brechignac, Philippe Rey, Philippe Collet, Mourad Tiab, Karim Belhadj, François Lifermann, Lauriane Clement-Filliatre, Claudine Sohn, Valentine Richez, Hervé Avet-Loiseau, null null
Improved survival in multiple myeloma during the 2005-2009 and 2010-2014 periods. Leukemia 35 (12) (2021)
Anaïs Schavgoulidze, Titouan Cazaubiel, Aurore Perrot, Hervé Avet-Loiseau, Jill Corre
Multiple Myeloma: Heterogeneous in Every Way. Cancers 13 (6) (2021)
Lucie Coster, Véronique De Mas, Laëtitia Largeaud, Sophie Voisin, Jill Corre, Martin Gauthier
Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR-ABL1 detection failure using RT-MLPA (positive RT-qPCR). EJHaem 2 (3) (2021)
Murielle Roussel, Valerie Lauwers-Cances, Soraya Wuilleme, Karim Belhadj, Salomon Manier, Laurent Garderet, Martine Escoffre-Barbe, Clara Mariette, Lofti Benboubker, Denis Caillot, Cécile Sonntag, Cyrille Touzeau, Jehan Dupuis, Philippe Moreau, Xavier Leleu, Thierry Facon, Benjamin Hébraud, Jill Corre, Michel Attal
Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results. Blood 138 (2) (2021)
Jean Baptiste Rieu, Aurore Perrot, Ines Vergnolle, Anais Schavgoulidze, Jill Corre
Multiple myeloma with hungry plasma cells. British journal of haematology 193 (3) (2021)
Lea Lemaitre, Malik Hamaidia, Jean-Gerard Descamps, Laura Do Souto Ferreira, Marie Veronique Joubert, Melanie Gadelorge, Hervé Avet-Loiseau, Arthur Justo, Nicolas Reina, Frederic Deschaseaux, Ludovic Martinet, Philippe Bourin, Jill Corre, Nicolas Espagnolle
Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth. Blood advances (2021)
Orancie Alcouffe, Vincent Mémier, Frederique Dubois-Galopin, Aurore Perrot, Jill Corre, Jean Baptiste Rieu
Double-hit multiple myeloma with atypical "faggot" cells. British journal of haematology (2021)
Alice Cleynen, Mehmet Samur, Aurore Perrot, Laure Buisson, Sabrina Maheo, Mariateresa Fulciniti, Michel Attal, Nikhil Munshi, Hervé Avet-Loiseau, Jill Corre
Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14). Blood 132 (26) (2018)

Jill Corre.css-eqlu8i{font-size:small;padding-left:4px;} (J Corre)

Publication Activity (10 Years)

Top Topics

Top Venues

Jill Corre (J Corre)